Navigation Links
Sequenom Announces Formation of Ophthalmology Clinical Advisory Board
Date:10/14/2010

services for prenatal and eye conditions. Utilizing innovative proprietary technologies, Sequenom CMM provides test results that can be used as tools by clinicians in managing patient care. Testing services are available only upon request to physicians. Sequenom CMM works closely with key opinion leaders and experts in obstetrics, retinal care and genetics. Sequenom CMM scientists use a variety of sophisticated and cutting-edge methodologies in the development and validation of tests. Sequenom CMM is changing the landscape in genetic diagnostics. Visit http://www.scmmlab.com for more information on laboratory services.

About Sequenom

Sequenom, Inc. (NASDAQ: SQNM) is a life sciences company committed to improving healthcare through revolutionary genetic analysis solutions. Sequenom develops innovative technology, products and diagnostic tests that target and serve discovery and clinical research, and molecular diagnostics markets. The company was founded in 1994 and is headquartered in San Diego, California. Sequenom maintains a Web site at http://www.sequenom.com to which Sequenom regularly posts copies of its press releases as well as additional information about Sequenom. Interested persons can subscribe on the Sequenom Web site to email alerts or RSS feeds that are sent automatically when Sequenom issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the Web site.

SEQUENOM®, Sequenom CMM®, are trademarks of Sequenom, Inc. All other trademarks and service marks are the property of their respective owners.

Forward-Looking Statements

Except for the historical information contained herein, the matters set forth in this press release, including statements regarding the Company's p
'/>"/>

SOURCE Sequenom, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Sequenom to Present at Two Financial Conferences in September
2. Sequenom to Present at Two Financial Conferences in March
3. Sequenom Appoints Two New Board Members
4. SEQUENOM Announces Partnership With GeneWorks for Sales & Marketing of MassARRAY Systems and Applications in Australia
5. SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights
6. SEQUENOM Announces Launch of MassARRAY Compact 96 System
7. SEQUENOM to Hold First Quarter 2009 Financial Results Conference Call on April 30
8. Webcast Alert: Sequenom: Defining the Future of Noninvasive Prenatal Diagnostics
9. Omeros Announces Additional Support from the National Institute on Drug Abuse for Clinical Studies in Addiction Program
10. Fate Therapeutics Announces Collaboration With BD to Develop and Commercialize Induced Pluripotent Stem Cell Technology
11. Osteotech Announces Early Termination of HSR Waiting Period
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... 26, 2015 Neogen Corporation (NASDAQ: NEOG ... third quarter of fiscal 2015, which ended Feb. 28, ... year,s $6,575,000. Earnings per share in the current quarter ... year-to-date net income increased 17% over prior year to ... $0.56 per share, for the same period a year ...
(Date:3/26/2015)... Gicqueau, Founder and President of Clinovo, will co-present with ... on “ Conducting Postmarket Registries - Rationale and Execution ... Exhibition on April 25th through April 28th in Salt ... Ale Gicqueau and Victor Chen will discuss the rationale ... and resources to conduct the registry, as well as ...
(Date:3/25/2015)... 2015 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") ... of recent discussions with certain shareholders representing approximately 45% ... after dealing with certain matters including the appointment of ... on March 26, 2015 (the "Meeting") it intends to ... will take place when the Meeting reconvenes. The Meeting ...
(Date:3/25/2015)... 25, 2015 Laboratory workers can ... and Analytical Balances to get best-performing features while ... weighing balances from the trusted brand include: , ... increase your efficiency by providing a large weighing ... Weighing modes include parts counting, percent weighing, checkweighing, ...
Breaking Biology Technology:Neogen reports 13% increase in net income 2Neogen reports 13% increase in net income 3Neogen reports 13% increase in net income 4Neogen reports 13% increase in net income 5Neogen reports 13% increase in net income 6Neogen reports 13% increase in net income 7Neogen reports 13% increase in net income 8Clinovo Presents at ACRP 2015 in Salt Lake City, Utah on April 25th-28th 2Clinovo Presents at ACRP 2015 in Salt Lake City, Utah on April 25th-28th 3SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 2SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 3SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 4SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 5New Economical Top-Loading and Analytical Symmetry Balances from Cole-Parmer 2
... PUNE, India, November 2 TeleDiagnosys based ... services has signed up,several new clients from US and ... Teleradiology services to an international clientele in,countries like USA, ... Teleradiology involves transmitting MRI, CT Scan and ...
... , PHILADELPHIA and LONDON, Nov. 2 A study from ... from China, far outpacing research activity in the rest of ... the USA within the next decade. , The study, ... research and collaboration potential of China and its current place ...
... SAN DIEGO, Oct. 31 Optimer Pharmaceuticals, Inc. (Nasdaq: ... data from fidaxomicin,s North American phase 3 study at ... of America (IDSA) in Philadelphia, PA. , (Logo: ... head of the Division of Infectious Diseases, Chair of ...
Cached Biology Technology:MRI & X-Ray Outsourcing Increasing From Hospitals and Imaging Centers Worldwide 2China's Research Output More Than Doubled Since 2004, Thomson Reuters Study Reveals 2Additional Data From Fidaxomicin's Phase 3 Study for Clostridium Difficile Infection (CDI) Presented at IDSA Annual Meeting 2Additional Data From Fidaxomicin's Phase 3 Study for Clostridium Difficile Infection (CDI) Presented at IDSA Annual Meeting 3Additional Data From Fidaxomicin's Phase 3 Study for Clostridium Difficile Infection (CDI) Presented at IDSA Annual Meeting 4
(Date:3/24/2015)... , March 24, 2015   NexID Biometrics ... with critical security-authentication needs, today announced the beginning of ... (FFD) solution. The company, based in ... at the three-day Connect:ID Expo, which began here today ... NexID said version 2.0 of its SDK boosts the ...
(Date:3/23/2015)... , March 23, 2015  In the 2014 ... fraud case conviction losses. This figure accounts for a ... according to The Nilson Report, exceeds $11 billion globally. ... tool after a crime has occurred. Investor Mark ... polygraph expert Joe Paolella partnered to administer ...
(Date:3/20/2015)... , March 20, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market, ... is one of the products featured in 2015 "I ... at 11:00 PM EST on the DIY Network.   ... Las Vegas , site of the 2015 ...
Breaking Biology News(10 mins):NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3
... research at York has revealed so-called Jekyll and Hyde ... without using insecticides. Researchers at the University of ... bacteria that live in them and discovered an ... insects. In fact, many insects thrive on plant food ...
... poll to reflect the discovery reported internationally in November ... stem cells or their near equivalents. When asked about ... 10, or 63 percent, say that both embryonic and ... say this development means embryonic stem cell research is ...
... RFID FOR STOCK ... AND STORE FRONT SOLUTION, SAN JOSE, Calif., Dec. 18 ... provider announced today the launch of a new product tailor-made,for the ... purpose is to provide the retail industry a total solution for,efficient ...
Cached Biology News:Widespread support for nonembryonic stem cell research, VCU Life Sciences Survey shows 2Titanium Group Announces Launch of New Identification Solution Targeting High Growth Retail Sector 2Titanium Group Announces Launch of New Identification Solution Targeting High Growth Retail Sector 3
... CRF The antibody blocks ... sequence that it was raised ... found in the paraventricular hypothalamic ... colchicine treated 4% FA perfused ...
... Custom Synthesis Service provides you ... to knockdown any gene. We ... base pairs with terminal dT ... other lengths of your choice. ...
... The Luminex 100 IS System is ... using Upstate's Beadlyte reagents. This system contains ... software developed by Luminex. The user can ... multiplex kits. The system has fully integrated ...
Polyclonal Antibody to HADHB...
Biology Products: